Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6)-Reference-Cited by-同舟云学术

Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6)

Published:2024-07-15 Issue:9 Volume:15 Page:2039-2059
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Boye Kristina Secnik^ORCID,Poon Jiat Ling^ORCID,Landó Laura Fernández^ORCID,Sapin Hélène^ORCID,Huh Ruth^ORCID,Wang Mianbo^ORCID,Williamson Suzanne^ORCID,Patel Hiren^ORCID

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13300-024-01620-8.pdf

Reference52 articles.

1. Saisho Y. β-cell dysfunction: its critical role in prevention and management of type 2 diabetes. World J Diabetes. 2015;6:109–24. https://doi.org/10.4239/wjd.v6.i1.109.

2. Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022;2022(45):2753–86. https://doi.org/10.2337/dci22-0034.

3. Swinnen SG, Hoekstra JB, DeVries JH. Insulin therapy for type 2 diabetes. Diabetes Care. 2009;32:S253–9. https://doi.org/10.2337/dc09-S318.

4. Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger PM. Insulin adherence behaviours and barriers in the multinational Global Attitudes to Patients and Physicians in Insulin Therapy study. Diabet Med. 2012;29:682–9. https://doi.org/10.1111/j.1464-5491.2012.03605.x.

5. Khunti K, Millar-Jones D. Clinical inertia to insulin initiation and intensification in the UK: a focused literature review. Prim Care Diabetes. 2017;11:3–12. https://doi.org/10.1016/j.pcd.2016.09.003.